• Je něco špatně v tomto záznamu ?

Dual-chamber leadless pacing: Atrioventricular synchrony in preclinical models of normal or blocked atrioventricular conduction

VY. Reddy, P. Neuzil, DF. Booth, RE. Knops, RN. Doshi, M. Rashtian, DV. Exner, RS. Banker, D. Nair, CA. Hadadi, N. Badie, W. Yang, D. Ligon, JE. Ip

. 2023 ; 20 (8) : 1146-1155. [pub] 20230417

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc23016762

BACKGROUND: Dual-chamber leadless pacemakers (LPs) require robust communication between distinct right atrial (RA) and right ventricular (RV) LPs to achieve atrioventricular (AV) synchrony. OBJECTIVE: The purpose of this preclinical study was to evaluate a novel, continuous implant-to-implant (i2iTM) communication methodology for maintaining AV-synchronous, dual-chamber DDD(R) pacing by the 2 LPs. METHODS: RA and RV LPs were implanted and paired in 7 ovine subjects (4 with induced complete heart block). AV synchrony (% AV intervals <300 ms) and i2i communication success (% successful i2i transmissions between LPs) were evaluated acutely and chronically. During acute testing, 12-lead electrocardiographic and LP diagnostic data were collected from 5-minute recordings, in 4 postures and 2 rhythms (AP-VP and AS-VP, or AP-VS and AS-VS) per subject. Chronic i2i performance was evaluated through 23 weeks postimplant (final i2i evaluation period: week 16-23). RESULTS: Acute AV synchrony and i2i communication success across multiple postures and rhythms were median [interquartile range] 100.0% [100.0%-100.0%] and 99.9% [99.9%-99.9%], respectively. AV synchrony and i2i success rates did not differ across postures (P = .59, P = .11) or rhythms (P = 1, P = .82). During the final i2i evaluation period, the overall i2i success was 98.9% [98.1%-99.0%]. CONCLUSION: Successful AV-synchronous, dual-chamber DDD(R) leadless pacing using a novel, continuous, wireless communication modality was demonstrated across variations in posture and rhythm in a preclinical model.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23016762
003      
CZ-PrNML
005      
20231026105553.0
007      
ta
008      
231013s2023 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.hrthm.2023.04.005 $2 doi
035    __
$a (PubMed)37075958
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Reddy, Vivek Y $u Icahn School of Medicine at Mount Sinai, New York, New York; Na Homolce Hospital, Prague, Czech Republic. Electronic address: vivek.reddy@mountsinai.org
245    10
$a Dual-chamber leadless pacing: Atrioventricular synchrony in preclinical models of normal or blocked atrioventricular conduction / $c VY. Reddy, P. Neuzil, DF. Booth, RE. Knops, RN. Doshi, M. Rashtian, DV. Exner, RS. Banker, D. Nair, CA. Hadadi, N. Badie, W. Yang, D. Ligon, JE. Ip
520    9_
$a BACKGROUND: Dual-chamber leadless pacemakers (LPs) require robust communication between distinct right atrial (RA) and right ventricular (RV) LPs to achieve atrioventricular (AV) synchrony. OBJECTIVE: The purpose of this preclinical study was to evaluate a novel, continuous implant-to-implant (i2iTM) communication methodology for maintaining AV-synchronous, dual-chamber DDD(R) pacing by the 2 LPs. METHODS: RA and RV LPs were implanted and paired in 7 ovine subjects (4 with induced complete heart block). AV synchrony (% AV intervals <300 ms) and i2i communication success (% successful i2i transmissions between LPs) were evaluated acutely and chronically. During acute testing, 12-lead electrocardiographic and LP diagnostic data were collected from 5-minute recordings, in 4 postures and 2 rhythms (AP-VP and AS-VP, or AP-VS and AS-VS) per subject. Chronic i2i performance was evaluated through 23 weeks postimplant (final i2i evaluation period: week 16-23). RESULTS: Acute AV synchrony and i2i communication success across multiple postures and rhythms were median [interquartile range] 100.0% [100.0%-100.0%] and 99.9% [99.9%-99.9%], respectively. AV synchrony and i2i success rates did not differ across postures (P = .59, P = .11) or rhythms (P = 1, P = .82). During the final i2i evaluation period, the overall i2i success was 98.9% [98.1%-99.0%]. CONCLUSION: Successful AV-synchronous, dual-chamber DDD(R) leadless pacing using a novel, continuous, wireless communication modality was demonstrated across variations in posture and rhythm in a preclinical model.
650    _2
$a lidé $7 D006801
650    _2
$a zvířata $7 D000818
650    _2
$a ovce $7 D012756
650    _2
$a kardiostimulace umělá $x metody $7 D002304
650    _2
$a lipopolysacharidy $7 D008070
650    12
$a kardiostimulátor $7 D010138
650    12
$a atrioventrikulární blokáda $x terapie $7 D054537
650    _2
$a srdeční frekvence $7 D006339
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Neuzil, Petr $u Na Homolce Hospital, Prague, Czech Republic
700    1_
$a Booth, Daniel F $u Abbott, Sylmar, California
700    1_
$a Knops, Reinoud E $u Academic Medical Center, Amsterdam, The Netherlands
700    1_
$a Doshi, Rahul N $u HonorHealth Research Institute, Scottsdale, Arizona
700    1_
$a Rashtian, Mayer $u Huntington Hospital, Pasadena, California
700    1_
$a Exner, Derek V $u Libin Cardiovascular Institute, Calgary, Alberta, Canada
700    1_
$a Banker, Rajesh S $u Hoag Memorial Hospital, Newport Beach, California
700    1_
$a Nair, Devi $u St. Bernard's Heart and Vascular Center, Jonesboro, Arkansas
700    1_
$a Hadadi, Cyrus A $u MedStar Washington Hospital Center, Washington, DC
700    1_
$a Badie, Nima $u Abbott, Sylmar, California
700    1_
$a Yang, Weiqun $u Abbott, Sylmar, California
700    1_
$a Ligon, David $u Abbott, Sylmar, California
700    1_
$a Ip, James E $u Weill Cornell Medical Center, New York, New York
773    0_
$w MED00156180 $t Heart rhythm $x 1556-3871 $g Roč. 20, č. 8 (2023), s. 1146-1155
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37075958 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231013 $b ABA008
991    __
$a 20231026105547 $b ABA008
999    __
$a ok $b bmc $g 2000346 $s 1203124
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 20 $c 8 $d 1146-1155 $e 20230417 $i 1556-3871 $m Heart rhythm $n Heart Rhythm $x MED00156180
LZP    __
$a Pubmed-20231013

Najít záznam

Citační ukazatele

Možnosti archivace